How should I evaluate and manage a mildly elevated aldosterone-to-renin ratio in a 52-year-old woman with mild hypertension who is taking a beta‑blocker?

Evaluation and Management of Mildly Elevated Aldosterone-to-Renin Ratio in a Patient on Beta-Blockers

You need to repeat the aldosterone-to-renin ratio (ARR) testing after withdrawing the beta-blocker for at least 2 weeks, as beta-blockers suppress renin and cause false-positive results, particularly when aldosterone levels are in the mildly elevated range like your patient's. 1, 2

Understanding the Current Result

Your patient's ARR of 84 is mildly elevated above the typical cutoff of 70, but this must be interpreted with extreme caution given beta-blocker use:

• Beta-blockers suppress renin levels, artificially elevating the ARR even in patients with essential hypertension 3
• The 2017 ACC/AHA guidelines explicitly state that beta-blockers should be withdrawn for 2 weeks before testing if safe and feasible 1, 2
• Research shows beta-blockers lead to false-positive results, particularly when aldosterone is between 10-15 ng/dL (277-416 pmol/L) by immunoassay 4

Algorithmic Approach to Retesting

Step 1: Medication Adjustment (4 weeks before retesting)

Withdraw for at least 4 weeks:

• Mineralocorticoid receptor antagonists (spironolactone, eplerenone)
• Potassium-sparing and potassium-wasting diuretics

Withdraw for at least 2 weeks:

• Beta-blockers (your patient's current issue)
• ACE inhibitors
• ARBs
• Dihydropyridine calcium channel blockers
• Centrally acting α2-agonists (clonidine, methyldopa) 5, 4

Acceptable alternatives for blood pressure control during this period:

• Non-dihydropyridine calcium channel blockers (verapamil, diltiazem)
• Alpha-blockers (doxazosin, prazosin, terazosin)
• Hydralazine 1, 2, 6

Step 2: Optimize Testing Conditions

Before blood draw:

• Correct any hypokalemia (measure plasma potassium carefully—slow draw with syringe, avoid fist clenching, separate plasma within 30 minutes) 4
• Ensure liberal sodium intake (unrestricted salt diet) 1, 2
• Patient should be ambulatory (sitting, standing, or walking) for at least 2 hours before testing 5
• Seated for 5-15 minutes immediately before blood draw 5
• Morning collection 5

Step 3: Interpret Repeat Testing

If ARR remains elevated after proper medication withdrawal:

The most commonly used cutoff is ARR >30 (when aldosterone is in ng/dL and renin activity in ng/mL/h), though your lab appears to use a cutoff of 70 1, 2. Critical requirement: plasma aldosterone must be ≥10 ng/dL to interpret a positive ARR 1, 2.

When to Proceed Without Medication Withdrawal

Do NOT attempt to withdraw beta-blockers if:

• Blood pressure cannot be adequately controlled with alternative agents
• Patient has severe or uncontrolled hypertension
• There are compelling cardiovascular indications for beta-blocker continuation

In such cases, recognize that the current ARR of 84 is likely a false-positive and primary aldosteronism is unlikely unless other high-risk features are present 1:

• Resistant hypertension (uncontrolled on 3+ drugs including a diuretic)
• Spontaneous or severe diuretic-induced hypokalemia
• Adrenal incidentaloma
• Family history of early-onset hypertension or stroke <40 years
• Age <40 with severe hypertension

Critical Pitfalls to Avoid

1. Do not proceed to confirmatory testing (saline suppression, oral salt loading) based on the current result while on beta-blockers—you will get false results 1, 2

2. Do not refer to endocrinology yet—first establish whether the elevated ARR persists off interfering medications 1

3. If you cannot safely withdraw the beta-blocker, consider that mild hypertension in a 52-year-old woman with an ARR of 84 on beta-blockers is most likely essential hypertension with a false-positive screen 3

4. Age matters: ARR increases with age even in essential hypertension. For patients ≥50 years, some data suggest higher cutoffs (ARR >3.7 when using certain units) may be more appropriate 7

If Repeat Testing Confirms Elevated ARR

Only after proper medication withdrawal and persistent elevation should you:

1. Perform confirmatory testing (IV saline suppression or oral salt loading) 1, 2
2. Refer to hypertension specialist or endocrinologist 1
3. Proceed with adrenal CT imaging and potentially adrenal venous sampling 1, 8

The bottom line: Beta-blockers are a well-established cause of false-positive ARR screening, and your patient's mildly elevated ratio of 84 cannot be reliably interpreted while she remains on this medication. 6, 3